Vuity in Nasdaq

By Contributor

October 30, 2021

FDA Approves Allergan’s VUITY As First Eye Drop to Treat Presbyopia

The FDA has approved Allergan’s, an AbbVie (ABBV) company, VUITY (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. …

Full story

  • Share This Story, Choose Your Platform!